238 related articles for article (PubMed ID: 26655167)
1. Three-dimensional tumor spheroids for in vitro analysis of bacteria as gene delivery vectors in tumor therapy.
Osswald A; Sun Z; Grimm V; Ampem G; Riegel K; Westendorf AM; Sommergruber W; Otte K; Dürre P; Riedel CU
Microb Cell Fact; 2015 Dec; 14():199. PubMed ID: 26655167
[TBL] [Abstract][Full Text] [Related]
2. Optimising non-viral gene delivery in a tumour spheroid model.
Mellor HR; Davies LA; Caspar H; Pringle CR; Hyde SC; Gill DR; Callaghan R
J Gene Med; 2006 Sep; 8(9):1160-70. PubMed ID: 16807955
[TBL] [Abstract][Full Text] [Related]
3. Anticancer efficacy of systemically delivered anaerobic bacteria as gene therapy vectors targeting tumor hypoxia/necrosis.
Liu SC; Minton NP; Giaccia AJ; Brown JM
Gene Ther; 2002 Feb; 9(4):291-6. PubMed ID: 11896468
[TBL] [Abstract][Full Text] [Related]
4. Modulation of extracellular matrix in cancer is associated with enhanced tumor cell targeting by bacteriophage vectors.
Yata T; Lee EL; Suwan K; Syed N; Asavarut P; Hajitou A
Mol Cancer; 2015 Jun; 14():110. PubMed ID: 26037383
[TBL] [Abstract][Full Text] [Related]
5. Employment of Salmonella in Cancer Gene Therapy.
Lee CH
Methods Mol Biol; 2016; 1409():79-83. PubMed ID: 26846804
[TBL] [Abstract][Full Text] [Related]
6. Induction of hypoxia and necrosis in multicellular tumor spheroids is associated with resistance to chemotherapy treatment.
Däster S; Amatruda N; Calabrese D; Ivanek R; Turrini E; Droeser RA; Zajac P; Fimognari C; Spagnoli GC; Iezzi G; Mele V; Muraro MG
Oncotarget; 2017 Jan; 8(1):1725-1736. PubMed ID: 27965457
[TBL] [Abstract][Full Text] [Related]
7. Anaerobic bacteria as a gene delivery system that is controlled by the tumor microenvironment.
Lemmon MJ; van Zijl P; Fox ME; Mauchline ML; Giaccia AJ; Minton NP; Brown JM
Gene Ther; 1997 Aug; 4(8):791-6. PubMed ID: 9338007
[TBL] [Abstract][Full Text] [Related]
8. Enhanced percolation and gene expression in tumor hypoxia by PEGylated polyplex micelles.
Han M; Oba M; Nishiyama N; Kano MR; Kizaka-Kondoh S; Kataoka K
Mol Ther; 2009 Aug; 17(8):1404-10. PubMed ID: 19471245
[TBL] [Abstract][Full Text] [Related]
9. [Application of microorganisms as delivery vehicles in cancer gene therapies].
Łepeta K; Łasica AM; Jagusztyn-Krynicka EK
Postepy Biochem; 2012; 58(3):314-26. PubMed ID: 23373417
[TBL] [Abstract][Full Text] [Related]
10. Multicellular Tumor Spheroids (MCTS) as a 3D In Vitro Evaluation Tool of Nanoparticles.
Lu H; Stenzel MH
Small; 2018 Mar; 14(13):e1702858. PubMed ID: 29450963
[TBL] [Abstract][Full Text] [Related]
11. Bacterial delivery of a novel cytolysin to hypoxic areas of solid tumors.
Ryan RM; Green J; Williams PJ; Tazzyman S; Hunt S; Harmey JH; Kehoe SC; Lewis CE
Gene Ther; 2009 Mar; 16(3):329-39. PubMed ID: 19177133
[TBL] [Abstract][Full Text] [Related]
12. Characteristics of multicellular tumor spheroids formed by pancreatic cells expressing different adhesion molecules.
Svirshchevskaya E; Doronina E; Grechikhina M; Matushevskaya E; Kotsareva O; Fattakhova G; Sapozhnikov A; Felix K
Life Sci; 2019 Feb; 219():343-352. PubMed ID: 30684543
[TBL] [Abstract][Full Text] [Related]
13. Anaerobic bacteria as a delivery system for cancer gene therapy: in vitro activation of 5-fluorocytosine by genetically engineered clostridia.
Fox ME; Lemmon MJ; Mauchline ML; Davis TO; Giaccia AJ; Minton NP; Brown JM
Gene Ther; 1996 Feb; 3(2):173-8. PubMed ID: 8867865
[TBL] [Abstract][Full Text] [Related]
14. Necrosis in DU145 prostate cancer spheroids induces COX-2/mPGES-1-derived PGE2 to promote tumor growth and to inhibit T cell activation.
Sha W; Olesch C; Hanaka H; Rådmark O; Weigert A; Brüne B
Int J Cancer; 2013 Oct; 133(7):1578-88. PubMed ID: 23536473
[TBL] [Abstract][Full Text] [Related]
15. Engineering a scaffold-free 3D tumor model for in vitro drug penetration studies.
Ong SM; Zhao Z; Arooz T; Zhao D; Zhang S; Du T; Wasser M; van Noort D; Yu H
Biomaterials; 2010 Feb; 31(6):1180-90. PubMed ID: 19889455
[TBL] [Abstract][Full Text] [Related]
16. Development of a hypoxia-inducible cytosine deaminase expression vector for gene-directed prodrug cancer therapy.
Wang D; Ruan H; Hu L; Lamborn KR; Kong EL; Rehemtulla A; Deen DF
Cancer Gene Ther; 2005 Mar; 12(3):276-83. PubMed ID: 15650767
[TBL] [Abstract][Full Text] [Related]
17. Modeling tumor cell adaptations to hypoxia in multicellular tumor spheroids.
Riffle S; Hegde RS
J Exp Clin Cancer Res; 2017 Aug; 36(1):102. PubMed ID: 28774341
[TBL] [Abstract][Full Text] [Related]
18. Adeno-associated viral vectors penetrate human solid tumor tissue in vivo more effectively than adenoviral vectors.
Enger PØ; Thorsen F; Lønning PE; Bjerkvig R; Hoover F
Hum Gene Ther; 2002 Jun; 13(9):1115-25. PubMed ID: 12067444
[TBL] [Abstract][Full Text] [Related]
19. Adeno-associated virus (AAV) serotypes 2, 4 and 5 display similar transduction profiles and penetrate solid tumor tissue in models of human glioma.
Thorsen F; Afione S; Huszthy PC; Tysnes BB; Svendsen A; Bjerkvig R; Kotin RM; Lønning PE; Hoover F
J Gene Med; 2006 Sep; 8(9):1131-40. PubMed ID: 16810631
[TBL] [Abstract][Full Text] [Related]
20. Implication of necrosis-linked p53 aggregation in acquired apoptotic resistance to 5-FU in MCF-7 multicellular tumour spheroids.
Lee SY; Jeong EK; Jeon HM; Kim CH; Kang HS
Oncol Rep; 2010 Jul; 24(1):73-9. PubMed ID: 20514446
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
